Clindamycin Impurity (Sulfone)
| Product Name | Clindamycin Impurity (Sulfone) |
|---|---|
| Alternate Names | Clindamycin Impurities, Impurities of Clindamycin |
| CAT No. | CS-P-07528 |
| CAS No. | 887402-22-4 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 456.98 g/mol |
| Mol. For. | C₁₈H₃₃ClN₂O₇S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Clindamycin |
| Therapeutic | Antibiotics |
| Smileys | O=C([C@@H]1N(C)C[C@H](CCC)C1)N[C@@H](C2[C@H](O)[C@@H](O)[C@H](O)[C@@H](S(=O)(C)=O)O2)[C@@H](Cl)C |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Clindamycin is a commonly used antibiotic in the treatment of bacterial infections. However, sometimes during the manufacturing process, impurities such as sulfones may be present in the final product. Clindamycin impurity (sulfone) is a byproduct of the synthesis of clindamycin, and is typically found in very small quantities.
This impurity is not intended for therapeutic use and is typically removed during the purification process. However, it is still important to understand the chemical properties and potential effects of clindamycin impurity (sulfone).
Chemically, clindamycin impurity (sulfone) is a compound containing a sulfur atom and two oxygen atoms. It is a stable compound and does not readily decompose or react with other chemicals. It is also insoluble in water, but soluble in organic solvents.
There is limited information available on the potential effects of clindamycin impurity (sulfone) on human health. However, it is generally considered to be a low-risk impurity, and there are no known reports of adverse effects resulting from its presence in clindamycin products.
In conclusion, while clindamycin impurity (sulfone) is not intended for therapeutic use, it is a byproduct of the synthesis of clindamycin and is typically present in very small quantities. While there is limited information on its potential effects, it is generally considered to be a low-risk impurity.
Get an Instant Quote
Related Compounds
Dipalmitate Impurity of Clindamycin | Clindamycin 2-Phosphate Sulfoxide Isomer A | Clindamycin Sulfoxide (S-Isomer) | Clindamycin Hydrochloride EP Impurity E | Clindamycin Sulfoxide palmitate isomer 2 | Clindamycin Palmitate Sulfoxide | Clindamycin 2-Phosphate Sulfoxide Isomer B | N-Desmethyl N-Nitroso Clindamycin (mixture of isomers) | Clindamycin B Palmitate | Clindamycin Phosphate EP Impurity K | Clindamycin 2-Phosphate Sulfoxide | Clindamycin 2,3-Dipalmitate Trifluoroacetic acid salt | Clindamycin Phosphate Sulfone trans-N-Oxide | Clindamycin Sulfoxide (R-Isomer) | Clindamycin B | Clindamycin B 3-Phosphate | Clindamycin 2-Phosphate Sulfone | Clindamycin Impurity 4 | Clindamycin Pyrophosphate Triethylamine Salt | Clindamycin 4-Phosphate | Clindamycin Phosphate EP Impurity I | Clindamycin Impurity L | Clindamycin Sulfoxide palmitate isomer | Clindamycin 4-Palmitate | Isopropylidene Clindamycin Phosphate | Dehydro Clindamycin | Clindamycin Phosphate N-Oxide | Clindamycin 2,4-Diphosphate | Clindamycin Impurity 9 | Clindamycin Impurity G | Clindamycin Myristate | Clindamycin 2,3-Dipalmitate |